Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Identifying and enumerating tumor-specific CD8 T cells are important for assessing cancer prognosis and therapy efficacy. Here the authors show that CD39 and CD103 mark a subset of tumor-infiltrating CD8 T cells that are tumor-reactive and exhibit characteristics of exhausted or tissue-resident memo...
Guardado en:
Autores principales: | Thomas Duhen, Rebekka Duhen, Ryan Montler, Jake Moses, Tarsem Moudgil, Noel F. de Miranda, Cheri P. Goodall, Tiffany C. Blair, Bernard A. Fox, Jason E. McDermott, Shu-Ching Chang, Gary Grunkemeier, Rom Leidner, Richard Bryan Bell, Andrew D. Weinberg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7f90edfb8d4e4077bb1febd57a7e1381 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
por: Jun Yan, et al.
Publicado: (2019) -
Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
por: Jun Yan, et al.
Publicado: (2019) -
TGFβR signalling controls CD103+CD11b+ dendritic cell development in the intestine
por: C. C. Bain, et al.
Publicado: (2017) -
CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function
por: Nicholas F. Kuhn, et al.
Publicado: (2020) -
CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis
por: Christian Barthels, et al.
Publicado: (2017)